Genetics Informatics Trial of Warfarin to Prevent DVT.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Warfarin (Primary)
- Indications Deep vein thrombosis; Pulmonary embolism; Thromboembolism
- Focus Adverse reactions; Pharmacogenomic; Therapeutic Use
- Acronyms GIFT
- 29 Dec 2016 Biomarkers information updated
- 25 Aug 2011 Actual initiation date changed from 1 Jul 2010 to 1 Mar 2011 as reported by ClinicalTrials.gov.
- 25 Aug 2011 Planned End Date changed from 1 Aug 2014 to 1 Aug 2015 as reported by ClinicalTrials.gov.